SUMO1 anticorps (C-Term)
Aperçu rapide pour SUMO1 anticorps (C-Term) (ABIN2369222)
Antigène
Voir toutes SUMO1 AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- AA 63-93, C-Term
-
Réactivité croisée
- Humain
-
Réactivité croisée (Details)
- Calculated cross reactivity: Hu
-
Attributs du produit
- SUMO1, CT (SUMO1, SMT3C, SMT3H3, UBL1, Small ubiquitin-related modifier 1, GAP-modifying protein 1, SMT3 homolog 3, Sentrin, Ubiquitin-homology domain protein PIC1, Ubiquitin-like protein SMT3C, Ubiquitin-like protein UBL1)
-
Purification
- Purified by Protein G affinity chromatography.
-
Immunogène
- SUMO1 antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 63~93 amino acids from the C-terminal region of human SUMO1.
-
Isotype
- IgG
-
-
-
-
Indications d'application
- Optimal working conditions should be determined by the investigator.
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Buffer
- Supplied as a liquid in PBS, pH 7.2, 0.09 % sodium azide.
-
Agent conservateur
- Sodium azide
-
Précaution d'utilisation
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Stock
- -20 °C
-
Stockage commentaire
- -20°C
-
-
- SUMO1 (Small Ubiquitin Related Modifier Protein 1 (SUMO1))
-
Autre désignation
- SUMO1
-
UniProt
- P63165
-
Pathways
- M Phase, Positive Regulation of Endopeptidase Activity, Protein targeting to Nucleus, Ubiquitin Proteasome Pathway
Antigène
-